| Trial ID: | L0862 |
| Source ID: | IRCT2014121620345N1
|
| Associated Drug: |
Chlorella Vulgaris
|
| Title: |
Comparison of Chlorella Vulgaris and Spirulina supplementation effect on oxidative stress, lipids profile and liver function in patients with Non-Alcoholic Fatty Liver
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver. <br>Non-Alcoholic Fatty Liver (Non-Alcoholic Steato Hepatitis);Non-Alcoholic Fatty Liver (Non-Alcoholic Steato Hepatitis)
|
| Interventions: |
Intervention 1: The intervention group will take 1 gram Spirulina (platensis ) supplementation, at least one hour before the lunch meal with a glass of water, which is for 8 weeks. Supplementations containing Spirulina microalgae will be purchased of Ghe
|
| Outcome Measures: |
Alanine Amino Transferase(ALT). Timepoint: Before and after 8 weeks. Method of measurement: Method :IFCC ( International Federation Clinical Chemistry) ? IU/L.;Aspartate Amin Transferase (AST). Timepoint: Before and after 8 weeks. Method of measurement: Method :IFCC ( International Federation Clinical Chemistry) ? IU/L.;Alkaline phosphatase (ALP). Timepoint: Before and after 8 weeks. Method of measurement: Method :IFCC ( International Federation Clinical Chemistry) ? IU/L.;TG (Triglyceride). Timepoint: Before and after 8 weeks. Method of measurement: Enzymatic (mg/dl).;TC (Total Cholesterol). Timepoint: Before and after 8 weeks. Method of measurement: Enzymatic (mg/dl).;LDL-C. Timepoint: Before and after 8 weeks. Method of measurement: Friedewald formula(mg/dl).;HDL-C. Timepoint: Before and after 8 weeks. Method of measurement: Deposit method(mg/dl).Serum Total Antioxidant Capacity (TAC). Timepoint: Before and after 8 weeks. Method of measurement: the DPPH (Diphenyl-2-Picrylhydrazyl) percentage reduction.;Serum Malon Di Aldehyde (MDA). Timepoint: Before and after 8 weeks. Method of measurement: based on Calorimetry.
|
| Sponsor/Collaborators: |
Vice Chancellor for Research Yazd Shahid Sadoughi University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years50 years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
72
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.
|
| Start Date: |
19/10/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of);Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/18044
|
